Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy [NA]
Clinical trial update examining how different anesthetics affect alarmins in patients with Non-Small Cell Lung Cancer undergoing pulmonary l…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Detecting EGFR T790M Mutations From Circulating Tumor Cells
This clinical trial update reports on methods to detect EGFR T790M mutations from circulating tumor cells in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Onartuzumab (MetMAb) in combination with Bevacizumab plus platinum and paclitaxel or with pemetrexed plus platinum …
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor
Completed clinical trial update assessing symptom improvement in patients with Non-Small-Cell Lung Cancer treated with a first-line EGFR tyr…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806) [Phase 2]
A Phase 2 study by the Japan Clinical Oncology Group evaluated preoperative chemoradiotherapy followed by surgical resection for Pancoast tu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This Phase 2 trial evaluating preoperative docetaxel alone or with cisplatin for C-stage IB-II non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403) [Phase 2]
This update notes the completion of a Phase II trial (JCOG0403) evaluating stereotactic body radiation therapy in patients with early-stage …
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating carboplatin, paclitaxel, bevacizumab, and vorinostat for advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2016-09-21Clinical Trial Update: Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET) [Phase 2]
Phase 2 COMET trial evaluating Tumor Treating Fields at 150 kHz in non-small cell lung cancer patients with 1-5 brain metastases after stand…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC [Phase 2]
This clinical trial update reports results from a Phase 2 study comparing BI 6727 (volasertib) alone and in combination with pemetrexed vers…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 1]
This update reports on a Phase 1 trial evaluating the PI3K inhibitor BKM-120 (buparlisib) in combination with carboplatin and pemetrexed for…
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
This clinical trial update describes a prospective study evaluating urinary circulating tumor DNA detection in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Europe-Japan Diagnostic Study for EGFR Testing
This document reports the completion of the Europe-Japan diagnostic trial NCT01785888 evaluating EGFR testing in patients with advanced non-…
-
CLINICAL_TRIALS withdrawal · 2016-09-20Clinical Trial Update: Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer [NA]
A clinical trial evaluating Amixea, a mixture of amino acids, in lean body mass and muscle strength for patients with unresectable advanced …
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy [Phase 3]
Phase 3 clinical trial update comparing sublobar resection versus lobectomy for elderly patients with early-stage non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2016-09-19Clinical Trial Update: First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating thymosin alpha-1 in combination with standard therapy as first-line treatment for patients with EGFR-m…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type [Phase 2]
This Phase 2 trial evaluates thymosin alpha-1 in combination with standard of care as maintenance therapy for patients with metastatic non-s…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial comparing weekly paclitaxel and carboplatin versus the standard paclitaxel and carboplatin regimen in stage IIIB or…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab [Phase 2]
A Phase 2 trial evaluating pazopanib in patients with stage IIIB/IV non-small cell lung cancer after progression on first-line therapy conta…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Validation of the MiCK Assay
The MiCK Assay validation trial (NCT01770665) sponsored by Pierian Biosciences has been terminated, involving mesothelioma, small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Elderly NSCLC/D vs DP (JCOG0207) [Phase 3]
A Phase 3 trial in elderly non-small cell lung cancer comparing regimens D and DP has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer
A clinical trial evaluating molecular diagnosis using circulating tumor DNA in non-small cell lung cancer (stages IIIb and IV) has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment [NA]
A terminated clinical trial evaluating yoga to improve quality of life in patients with non-small cell lung cancer undergoing treatment.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab with or without Cixutumumab in stage IV or recurrent non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers [Phase 1]
Phase 1 safety study of MM-121 in combination with cetuximab and irinotecan in patients with advanced cancers, including colorectal cancer a…